Market Place
Sourcing Support
IsoPlexis Reports Preliminary Full Year 2022 Revenue
12 Jan 2023 //
GLOBENEWSWIRE
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology
21 Dec 2022 //
GLOBENEWSWIRE
IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022
19 Oct 2022 //
GLOBENEWSWIRE
IsoPlexis Announces First APAC Publication, Illustrating Early Impact Codeplex
13 Sep 2022 //
GLOBENEWSWIRE
IsoPlexis Partners with MediMergent & The Center for Blood Disorders of AZD7442
06 Sep 2022 //
GLOBENEWSWIRE
IsoPlexis Appointments Nachum “Homi” Shamir to its Board of Directors
23 Aug 2022 //
GLOBENEWSWIRE
IsoPlexis Reports First Quarter 2022 Financial Results
11 May 2022 //
GLOBENEWSWIRE
IsoPlexis Reports Preliminary Q1 2022 Revenue
11 Apr 2022 //
GLOBENEWSWIRE
IsoPlexis to Present Data on Simultaneous Single Cell TCR Profiling
08 Apr 2022 //
GLOBENEWSWIRE
IsoPlexis Reports Q4 and Full Year 2021 Financial Results
02 Mar 2022 //
GLOBENEWSWIRE
IsoPlexis to Participate in Three Upcoming Investor Conferences
11 Feb 2022 //
GLOBENEWSWIRE
IsoPlexis Reports Preliminary Full Year 2021 Revenue
09 Jan 2022 //
GLOBENEWSWIRE
IsoPlexis drops more 20% on trading debut
08 Oct 2021 //
SEEKINGALPHA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.